About Medasense

Helping clinicians achieve personalized and optimized pain management

Medasense is spearheading pain management to achieve optimized and personalized care with improved outcomes.

While pain is a major clinical, social and economic problem, affecting quality of life for hundreds of millions of people globally, measurement of pain has remained subjective. Consequently, pain care is not tailored to patients’ specific needs, opioid addiction has become an epidemic, and the direct costs of pain-related healthcare are soaring.

Addressing this problem, Medasense’s NOL® technology is enabling clinicians to personalize pain management, optimize treatment and avoid overmedication with an innovative noninvasive sensor platform and AI technology.

Latest News

NOL pain response monitoring has been approved for marketing in Brazil.

>

A new study has found that monitoring pain response levels during surgery with NOL technology can help reduce postoperative pain.

>

Medasense announces closing its $18M series C investment round.

>

Global Distribution Network